American Century Companies’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,699
Closed -$329K 2929
2026
Q1
$329K Buy
12,699
+4,614
+57% +$133K ﹤0.01% 2617
2025
Q4
$220K Buy
+8,085
New +$142K ﹤0.01% 2691

Other funds holding FBRX

American Century Companies's FBRX Position: Q2 2026 in Review

American Century Companies sold out of Forte Biosciences (FBRX) in Q2 2026, closing a stake of 12,699 shares — an estimated $329K sold.

American Century Companies first reported a position in FBRX in Q4 2025 and held it in 2 quarters. The position peaked at $329K in Q1 2026. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • American Century Companies reported no remaining Forte Biosciences position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 12,699 Forte Biosciences shares in Q2 2026, an estimated $329K.
  • American Century Companies first reported a position in Forte Biosciences in Q4 2025 and held it in 2 quarters.
  • American Century Companies's Forte Biosciences position peaked at $329K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.